MetaADEDB 2.0 @ LMMD
nepafenac
(QEFAQIPZVLVERP-UHFFFAOYSA-N)
Structure
SMILES
NC(=O)Cc1cccc(c1N)C(=O)c1ccccc1
Type(s)
Approved; Investigational
ATC code(s)
S01BC10
Molecular Formula:
C15H14N2O2
Molecular Weight:
254.284
Log P:
2.8091
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
2
TPSA:
86.18
CAS Number(s):
78281-72-8
Synonym(s)
1.
nepafenac
2.
2-amino-3-benzoylbenzeneacetamide
3.
Nevanac
External Link(s)
MeSHC414203
PubChem Compound151075
BindingDB50228731
ChEBI75922
CHEMBLCHEMBL1021
DrugBankDB06802
DrugCentral1899
IUPHAR/BPS Guide to PHARMACOLOGY7564
KEGGdr:D05143
Therapeutic Target DatabaseD02IHW
ZINC5162311
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Eye painFAERS: 361OFFSIDES
SIDER
US FAERS
2Drug ineffectiveFAERS: 215
Canada Vigilance: 2
Canada Vigilance
US FAERS
3Liquid product physical issueFAERS: 37US FAERS
4Eye irritationFAERS: 34
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
5Product quality issueFAERS: 27US FAERS
6Therapy partial responderFAERS: 26US FAERS
7Visual ImpairmentFAERS: 14US FAERS
8Incorrect dose administeredFAERS: 13US FAERS
9Punctate keratitisFAERS: 13OFFSIDES
SIDER
US FAERS
10Product packaging quantity issueFAERS: 12US FAERS
11Foreign body sensation in eyesFAERS: 11OFFSIDES
SIDER
US FAERS
12Product physical consistency issueFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
13Ocular ToxicityFAERS: 10US FAERS
14Corneal OpacityFAERS: 9SIDER
US FAERS
15PhotophobiaFAERS: 9SIDER
US FAERS
16Product container issueFAERS: 9US FAERS
17NauseaFAERS: 8OFFSIDES
SIDER
US FAERS
18Ocular discomfortFAERS: 8
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
19PainFAERS: 8OFFSIDES
US FAERS
20Product dropper issueFAERS: 8US FAERS
21Therapeutic response delayedFAERS: 8US FAERS
22Drug administration errorFAERS: 7US FAERS
23Malabsorption from application siteFAERS: 7US FAERS
24Eye inflammationFAERS: 6OFFSIDES
US FAERS
25HeadacheFAERS: 6SIDER
US FAERS
26Corneal epithelium defectFAERS: 5OFFSIDES
SIDER
US FAERS
27DizzinessFAERS: 5SIDER
US FAERS
28Feeling abnormalFAERS: 5OFFSIDES
US FAERS
29HypersensitivityFAERS: 5SIDER
US FAERS
30InflammationFAERS: 5US FAERS
31No adverse eventFAERS: 5US FAERS
32Product physical issueFAERS: 5US FAERS
33Abdominal discomfortFAERS: 4US FAERS
34Chest discomfortFAERS: 4US FAERS
35Corneal PerforationFAERS: 4US FAERS
36Drug prescribing errorFAERS: 4US FAERS
37Expired product administeredFAERS: 4US FAERS
38Eyelid margin crustingFAERS: 4SIDER
US FAERS
39Medication residue presentFAERS: 4US FAERS
40PalpitationsFAERS: 4US FAERS
41Product administration errorFAERS: 4US FAERS
42Toxicity to various agentsFAERS: 4US FAERS
43Accidental exposure to productFAERS: 3US FAERS
44BlindnessFAERS: 3US FAERS
45Cerebrovascular accidentFAERS: 3US FAERS
46Corneal ScarFAERS: 3OFFSIDES
SIDER
US FAERS
47DiplopiaFAERS: 3US FAERS
48DyspepsiaFAERS: 3US FAERS
49Inappropriate schedule of drug administrationFAERS: 3US FAERS
50MalaiseFAERS: 3US FAERS
51Poor quality drug administeredFAERS: 3US FAERS
52Post procedural complicationFAERS: 3OFFSIDES
US FAERS
53Product use complaintFAERS: 3US FAERS
54Product use in unapproved indicationFAERS: 3US FAERS
55PruritusFAERS: 3SIDER
US FAERS
56Retinal DetachmentFAERS: 3US FAERS
57SinusitisFAERS: 3SIDER
US FAERS
58Visual disturbanceFAERS: 3OFFSIDES
US FAERS
59Atrial FibrillationFAERS: 2US FAERS
60BlepharospasmFAERS: 2US FAERS
61CataractFAERS: 2OFFSIDES
SIDER
US FAERS
62Chest PainFAERS: 2OFFSIDES
US FAERS
63Corneal epithelium disorderFAERS: 2OFFSIDES
US FAERS
64Corneal erosionFAERS: 2OFFSIDES
US FAERS
65Corneal irritationFAERS: 2US FAERS
66Corneal thinningFAERS: 2OFFSIDES
SIDER
US FAERS
67Drug dispensing errorFAERS: 2US FAERS
68EndophthalmitisFAERS: 2SIDER
US FAERS
69ErythemaFAERS: 2US FAERS
70FatigueFAERS: 2US FAERS
71GlaucomaFAERS: 2OFFSIDES
US FAERS
72HypopyonFAERS: 2US FAERS
73IritisFAERS: 2OFFSIDES
SIDER
US FAERS
74KeratitisFAERS: 2SIDER
US FAERS
75Macular degenerationFAERS: 2US FAERS
76Medication ErrorFAERS: 2US FAERS
77Muscle strainFAERS: 2US FAERS
78MydriasisFAERS: 2US FAERS
79NervousnessFAERS: 2US FAERS
80Product package associated injuryFAERS: 2US FAERS
81Product packaging issueFAERS: 2US FAERS
82Product use issueFAERS: 2US FAERS
83UrticariaFAERS: 2US FAERS
84UveitisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
85Vitreous floatersFAERS: 2US FAERS
86Wrong technique in product usage processFAERS: 2US FAERS
87Accidental overdoseFAERS: 1OFFSIDES
US FAERS
88AngioedemaFAERS: 1US FAERS
89Angle Closure GlaucomaFAERS: 1US FAERS
90Application site burnFAERS: 1US FAERS
91ArthralgiaFAERS: 1US FAERS
92ArthritisFAERS: 1SIDER
US FAERS
93AsthenopiaFAERS: 1OFFSIDES
US FAERS
94AstigmatismFAERS: 1US FAERS
95Blood glucose increasedFAERS: 1US FAERS
96ChorioretinitisFAERS: 1US FAERS
97ChromaturiaFAERS: 1US FAERS
98Chronic sinusitisFAERS: 1US FAERS
99Ciliary zonular dehiscenceFAERS: 1US FAERS
100Cold sweatFAERS: 1US FAERS
101Conjunctival scarFAERS: 1US FAERS
102Consciousness fluctuatingFAERS: 1US FAERS
103ConstipationFAERS: 1US FAERS
104Contraindicated product administeredFAERS: 1US FAERS
105Corneal decompensationFAERS: 1US FAERS
106Corneal defectFAERS: 1US FAERS
107Corneal degenerationFAERS: 1US FAERS
108Corneal exfoliationFAERS: 1US FAERS
109Corneal hypertrophyFAERS: 1US FAERS
110DeafnessFAERS: 1US FAERS
111Depressed moodFAERS: 1US FAERS
112Device dislocationFAERS: 1US FAERS
113DiscomfortFAERS: 1US FAERS
114Disease ProgressionFAERS: 1US FAERS
115Drug ToleranceFAERS: 1US FAERS
116Drug ineffective for unapproved indicationFAERS: 1US FAERS
117DysgraphiaFAERS: 1US FAERS
118EczemaFAERS: 1US FAERS
119EpistaxisFAERS: 1US FAERS
120Excessive eye blinkingFAERS: 1US FAERS
121Eye InfectionFAERS: 1US FAERS
122Eye allergyFAERS: 1US FAERS
123Eye operation complicationFAERS: 1US FAERS
124FlushingFAERS: 1US FAERS
125Gaze palsyFAERS: 1US FAERS
126Genital rashFAERS: 1US FAERS
127HemiparesisFAERS: 1US FAERS
128Impaired driving abilityFAERS: 1OFFSIDES
US FAERS
129Incorrect drug administration durationFAERS: 1US FAERS
130Incorrect product administration durationFAERS: 1US FAERS
131Instillation site painFAERS: 1US FAERS
132Intraocular pressure test abnormalFAERS: 1US FAERS
133Lip swellingFAERS: 1US FAERS
134Mastication disorderFAERS: 1US FAERS
135Muscle tightnessFAERS: 1US FAERS
136NasopharyngitisFAERS: 1US FAERS
137Ocular icterusFAERS: 1US FAERS
138Optic NeuropathyFAERS: 1US FAERS
139OverdoseFAERS: 1US FAERS
140Pancreatic carcinomaFAERS: 1US FAERS
141Paranasal sinus discomfortFAERS: 1US FAERS
142Pharmaceutical product complaintFAERS: 1US FAERS
143Pharyngeal swellingFAERS: 1US FAERS
144PingueculaFAERS: 1US FAERS
145Product contamination microbialFAERS: 1US FAERS
146Product depositFAERS: 1US FAERS
147Product formulation issueFAERS: 1US FAERS
148Product gel formationFAERS: 1US FAERS
149Product residue presentFAERS: 1US FAERS
150Product storage errorFAERS: 1US FAERS
151PterygiumFAERS: 1US FAERS
152RetchingFAERS: 1US FAERS
153Retinal Vascular DisorderFAERS: 1US FAERS
154RetinitisFAERS: 1US FAERS
155ScleritisFAERS: 1OFFSIDES
US FAERS
156Skin irritationFAERS: 1US FAERS
157SwellingFAERS: 1US FAERS
158SyncopeFAERS: 1US FAERS
159Therapeutic product effect delayedFAERS: 1US FAERS
160Throat irritationFAERS: 1US FAERS
161ToxoplasmosisFAERS: 1US FAERS
162Unevaluable eventFAERS: 1OFFSIDES
US FAERS
163VertigoFAERS: 1US FAERS
164Vitreous DetachmentFAERS: 1SIDER
US FAERS
165VomitingFAERS: 1SIDER
US FAERS
166Wrong technique in drug usage processFAERS: 1US FAERS
167Abdominal PainOFFSIDES
168Acanthamoeba InfectionOFFSIDES
169Acquired diaphragmatic eventrationOFFSIDES
170Activities of daily living impairedOFFSIDES
171AlopeciaOFFSIDES
172AmnesiaOFFSIDES
173AngiomyolipomaOFFSIDES
174AnhedoniaOFFSIDES
175Anterior chamber inflammationOFFSIDES
176AnxietyOFFSIDES
177ApathyOFFSIDES
178AstheniaOFFSIDES
179Bacillus infectionOFFSIDES
180BlepharitisSIDER
181BlepharoptosisOFFSIDES
182Blood GlucoseOFFSIDES
183Blood creatine increasedOFFSIDES
184Blood glucose decreasedOFFSIDES
185Blurred visionOFFSIDES
186Cataract operationOFFSIDES
187Conjunctival depositOFFSIDES
188Corneal InfectionOFFSIDES
189Corneal UlcerOFFSIDES
190Culture positiveOFFSIDES
191Cutis LaxaSIDER
192DehydrationOFFSIDES
193Dental cariesOFFSIDES
194Diabetes MellitusSIDER
195Drug toxicityOFFSIDES
196Drug withdrawal headacheOFFSIDES
197Economic problemOFFSIDES
198Escherichia infectionOFFSIDES
199Eyelids pruritusOFFSIDES
200GastroduodenitisOFFSIDES
201Glaucoma surgeryOFFSIDES
202GlobulinuriaOFFSIDES
203GlossitisOFFSIDES
204GoiterOFFSIDES
205Grip strengthOFFSIDES
206HepatitisOFFSIDES
207Iatrogenic injuryOFFSIDES
208Intentional drug misuseOFFSIDES
209Intraocular inflammationOFFSIDES
210Intraocular pressure fluctuationOFFSIDES
211Laboratory test interferenceOFFSIDES
212Lacrimation decreasedSIDER
213LacrimationSIDER
214Musculoskeletal stiffnessOFFSIDES
215NoduleOFFSIDES
216Non-cardiac chest painOFFSIDES
217OnychoclasisOFFSIDES
218OsteopeniaOFFSIDES
219PancreatitisOFFSIDES
220PregnancySIDER
221RalesOFFSIDES
222Residual urineOFFSIDES
223Rheumatoid ArthritisSIDER
224ScabSIDER
225Skin lacerationOFFSIDES
226Sleep-related eating disorderOFFSIDES
227Stevens-Johnson SyndromeOFFSIDES
228TenosynovitisOFFSIDES
229TrabeculectomyOFFSIDES
230UlcerOFFSIDES
231Vascular ruptureOFFSIDES
232nervous system disorderSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.